# CHroniSense National Early Warning Score Study

> **NCT03448861** · NA · UNKNOWN · sponsor: **BlueWind Medical** · enrollment: 250 (estimated)

## Conditions studied

- Clinical Assessment

## Interventions

- **DEVICE:** Polso Wearebale watch

## Key facts

- **NCT ID:** NCT03448861
- **Lead sponsor:** BlueWind Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-11
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2018-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448861, "CHroniSense National Early Warning Score Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03448861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
